YOLFTbeta
68

Zhejiang HISUN Biomaterials Co. Ltd. A

688203 · SHG · Basic Materials / Chemicals

14.45CNY-0.84 (-5.49%)

Price History

Full chart

Market Stats

Previous Close15.29
Open15.25
Day Range14.45 – 15.50
52-Week Range8.38 – 26.35
Volume14.32M
Market Cap3.84B
P/E (TTM)145.77
Forward P/E0.00
EPS0.13
Dividend Yield0.00%
Beta0.79
50-Day Avg13.48
200-Day Avg12.72

About

Zhejiang Hisun Biomaterials Co.Ltd. engages in the research, development, production, and sale of polylactic acid in China. Its products are used in various applications that include 3D printing, extrusion, thermoforming, film blowing and laminating, injection molding, meltblown non-woven fabric, and injection blow molding. The company was founded in 2004 and is headquartered in Taizhou, China.

Company Details

  • SectorBasic Materials
  • IndustryChemicals
  • CEOMr. Zhiming Chen
  • Employees472
  • HeadquartersNo. 188, Taizhou Bay Avenue, Taizhou, China, 318000, China
  • Websitehttps://www.hisunplas.com

Leadership

  • Mr. Zhiming ChenGM & Director · b. 1962
  • Ms. Jiao JieFinancial Director · b. 1991
  • Ms. Zhang MinSecretary of the Board · b. 1981
  • Mr. Wei LiangDeputy General Manager · b. 1982
  • Mr. Zhao Lu RuanDeputy General Manager · b. 1966
  • Mr. Maoxin ZengHead of Accounting Department

Financials

Income Statement

Currency: CNY2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue262.66M585.01M605.43M753.32M845.19M851.69M
Growth (%)-+122.72%+3.49%+24.43%+12.20%+0.77%
Cost of Revenue194.42M496.84M524.45M654.54M739.34M760.19M
Gross Profit68.24M88.16M80.98M98.77M105.85M91.51M
Gross Margin25.98%15.07%13.38%13.11%12.52%10.74%
Operating Expense040.37M39.99M57.85M59.09M70.56M
Operating Income68.24M47.79M40.99M40.92M46.76M20.95M
Operating Margin25.98%8.17%6.77%5.43%5.53%2.46%
EBITDA--105.09M115.46M120.28M93.81M
EBITDA Margin--17.36%15.33%14.23%11.01%
Net Income30.38M35.27M47.04M43.55M35.50M9.87M
Net Income Margin11.57%6.03%7.77%5.78%4.20%1.16%
R&D9.30M14.16M19.03M25.89M27.27M29.59M
R&D as % of Total Revenue3.54%2.42%3.14%3.44%3.23%3.47%
Interest Expense6.87M10.76M9.63M7.48M7.59M6.08M
Interest Expense % of Total Revenue2.61%1.84%1.59%0.99%0.90%0.71%

Balance Sheet

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-1.17B1.18B1.93B2.05B2.07B2.05B
Total Liabilities-555.36M529.26M476.56M569.25M574.05M570.43M
Total Equity-619.36M653.99M1.45B1.48B1.49B1.48B
Cash-593.68M248.81M938.49M855.70M515.73M328.30M
Net Debt109.18M-84.03M----

Cash Flow

Currency: CNY2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow28.66M71.18M136.15M163.03M38.84M20.84M
Capital Expenditure198.08M309.44M225.27M214.11M293.18M127.16M
Free Cash Flow28.66M-238.26M-89.13M-51.08M-254.34M-106.32M
Dividends Paid12.76M14.44M15.83M23.33M23.59M18.15M
FCF to OCF100.00%-334.73%-65.47%-31.33%-654.92%-510.10%
Dividend Paid to FCF44.51%-6.06%-17.76%-45.67%-9.27%-17.07%

Earnings

Report DateDec 31, 2022Mar 31, 2023
EPS Estimate--
EPS Actual0.020.02
Surprise--
Timing--

Key Statistics & Ratios

Market Cap3.84B
Enterprise Value4.84B
Trailing P/E145.77
Forward P/E0.00
Price / Sales3.66
Price / Book3.29
EPS0.13
Book Value7.46
Revenue (TTM)1.05B
Gross Profit (TTM)127.86M
EBITDA122.47M
Profit Margin2.63%
Operating Margin8.27%
Return on Equity1.86%
Return on Assets1.24%
Shares Outstanding202.68M
Shares Float81.66M
Beta0.79
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20251×
0.06Jun 6, 2025
20241×
0.08May 9, 2024
20231×
0.07Apr 28, 2023